|
Volumn 322, Issue 5899, 2008, Pages 220-223
|
Cholesterol veers off script
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
C REACTIVE PROTEIN;
CHOLESTEROL ESTER TRANSFER PROTEIN;
EZETIMIBE;
EZETIMIBE PLUS SIMVASTATIN;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
MEVINOLIN;
ROSUVASTATIN;
SIMVASTATIN;
TORCETRAPIB;
HYPOCHOLESTEROLEMIC AGENT;
BLOOD;
CARDIOLOGY;
DRUG;
FAT;
MEDICINE;
ANTIINFLAMMATORY ACTIVITY;
ATHEROSCLEROSIS;
CARDIOVASCULAR DISEASE;
CHOLESTEROL BLOOD LEVEL;
CHOLESTEROL METABOLISM;
CLINICAL TRIAL;
HEART PROTECTION;
HUMAN;
HYPERCHOLESTEROLEMIA;
PRIORITY JOURNAL;
SHORT SURVEY;
BLOOD;
CORONARY ARTERY DISEASE;
GENETICS;
HEART DISEASE;
NOTE;
ANTICHOLESTEREMIC AGENTS;
C-REACTIVE PROTEIN;
CHOLESTEROL, HDL;
CHOLESTEROL, LDL;
CLINICAL TRIALS AS TOPIC;
CORONARY ARTERY DISEASE;
HEART DISEASES;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
|
EID: 53749106592
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.322.5899.220 Document Type: Short Survey |
Times cited : (18)
|
References (0)
|